Physician profile

Alan Mcnamara

Obstetrics & Gynecology · Fall River, MA

NPI 1124392980

$345.00

in general payments reported to CMS, 2019-2025

11 companies · none reported in 2025

See the full distribution for Obstetrics & Gynecology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$130.17

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $167.68 2020-2023
Sumitomo Pharma America, INC. $27.46 2023 Myfembree
Hologic Sales and Service, LLC $20.79 2023 Aptima
Organon LLC $20.19 2023 Nexplanon
Mylan Pharmaceuticals INC. $19.81 2021
Bayer Healthcare Pharmaceuticals INC. $19.75 2019
Evofem Biosciences, INC. $17.97 2021
Becton, Dickinson and Company $13.72 2019
Pfizer INC. $13.53 2019
Dysis Medical, INC. $12.20 2019
Channel Medsystems, INC. $11.90 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Alan Mcnamara

$345.00

in general payments reported 2019-2025

Years
2019-2023
Top company
Abbvie INC.

https://glasscript.com/doctor/278435/alan-mcnamara

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.